Your browser doesn't support javascript.
loading
Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience.
Moné, M J; Pallocca, G; Escher, S E; Exner, T; Herzler, M; Bennekou, S Hougaard; Kamp, H; Kroese, E D; Leist, Marcel; Steger-Hartmann, T; van de Water, B.
Afiliación
  • Moné MJ; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Pallocca G; CAAT-Europe at the University of Konstanz, Constance, Germany.
  • Escher SE; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Hannover, Germany.
  • Exner T; Edelweiss Connect GmbH, Basel, Switzerland.
  • Herzler M; German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
  • Bennekou SH; Technical University of Denmark, Kongens Lyngby, Denmark.
  • Kamp H; BASF SE, Ludwigshafen, Germany.
  • Kroese ED; TNO Innovation for Life, Utrecht, The Netherlands.
  • Leist M; CAAT-Europe at the University of Konstanz, Constance, Germany. marcel.leist@uni-konstanz.de.
  • Steger-Hartmann T; In Vitro Toxicology and Biomedicine, Department Inaugurated By the Doerenkamp-Zbinden Foundation at the University of Konstanz, University of Konstanz, 78457, Constance, Germany. marcel.leist@uni-konstanz.de.
  • van de Water B; Investigational Toxicology, Bayer AG, Pharmaceuticals, Berlin, Germany.
Arch Toxicol ; 94(10): 3581-3592, 2020 10.
Article en En | MEDLINE | ID: mdl-32886186
In 2016, the European Commission launched the EU-ToxRisk research project to develop and promote animal-free approaches in toxicology. The 36 partners of this consortium used in vitro and in silico methods in the context of case studies (CSs). These CSs included both compounds with a highly defined target (e.g. mitochondrial respiratory chain inhibitors) as well as compounds with poorly defined molecular initiation events (e.g. short-chain branched carboxylic acids). The initial project focus was on developing a science-based strategy for read-across (RAx) as an animal-free approach in chemical risk assessment. Moreover, seamless incorporation of new approach method (NAM) data into this process (= NAM-enhanced RAx) was explored. Here, the EU-ToxRisk consortium has collated its scientific and regulatory learnings from this particular project objective. For all CSs, a mechanistic hypothesis (in the form of an adverse outcome pathway) guided the safety evaluation. ADME data were generated from NAMs and used for comprehensive physiological-based kinetic modelling. Quality assurance and data management were optimized in parallel. Scientific and Regulatory Advisory Boards played a vital role in assessing the practical applicability of the new approaches. In a next step, external stakeholders evaluated the usefulness of NAMs in the context of RAx CSs for regulatory acceptance. For instance, the CSs were included in the OECD CS portfolio for the Integrated Approach to Testing and Assessment project. Feedback from regulators and other stakeholders was collected at several stages. Future chemical safety science projects can draw from this experience to implement systems toxicology-guided, animal-free next-generation risk assessment.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxicología / Investigación Biomédica / Rutas de Resultados Adversos / Alternativas a las Pruebas en Animales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Arch Toxicol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxicología / Investigación Biomédica / Rutas de Resultados Adversos / Alternativas a las Pruebas en Animales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Arch Toxicol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Alemania